AGX817

SARS-CoV-2 Spike Protein S1 (aa 1-674) Recombinant Antigen

recombinant, expressed in HEK 293 cells

• Synonyme(s) : 2019-nCoV, COVID-19, Wuhan-Hu-1
• Code UNSPSC : 51201600
• Nomenclature NACRES : NA.26

Propriétés

• Produit recombinant: expressed in HEK 293 cells
• Niveau de qualité: 100
• Forme: liquid
• Conditions de stockage: avoid repeated freeze/thaw cycles
• Conditions d'expédition: dry ice

Description

Description générale

COVID-19 Spike Protein S1 (aa 1-674) Recombinant Antigen, expressed in HEK293 cells, Cat. No. AGX817 is tested for as Positive Control.

Description de la cible

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by the virus strain severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a virus closely related to the SARS virus. A SARS-CoV-2 spike antigen can be used to support the detection of SARS-CoV-2 (COVID-19, 2019-nCoV).

Forme physique

Purified protein in DPBS without preservatives, pH 7.4.

Reconstitution

Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Stockage et stabilité

Stable for 1 year at -70°C. Avoid repeated freeze/thaw cycles

Clause de non-responsabilité

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

Informations sur la sécurité

• Code de la classe de stockage: 12 - Non Combustible Liquids
• Classe de danger pour l'eau (WGK): WGK 2
• Point d'éclair (°F): Not applicable
• Point d'éclair (°C): Not applicable